Regeneron Pharmaceuticals 2024 Corporate Presentation

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Regeneron Pharmaceuticals corporate presentation from February 2024 covering pipeline updates, clinical programs, and forward-looking guidance. Includes data on marketed products including EYLEA HD, Dupixent, and Libtayo, as well as investigational candidates in oncology and other therapeutic areas. Contains non-GAAP financial measures and risk disclosures for investors.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Regeneron Pharmaceuticals, Inc.

View all →

Regeneron Pharmaceuticals 2016 Bank of America Healthcare Conference

conference

23 Pages

Regeneron Pharmaceuticals 2022 Corporate Investor Presentation

investor_presentation

Similar investor_presentations from other companies

Browse all →

Weyerhaeuser 2020 Investor Meeting Presentation

investor_presentation

60 Pages

Weyerhaeuser Company

Novo Banco Investor Presentation November 2023

investor_presentation